HMGCR and neoplasm: Furthermore, the aberrant activity of 3-hydroxy-3-methylglutaryl coenzyme A (HMGCoA) reductase (HMGCR), the rate-limiting enzyme of MVA pathway, can promote malignant transformation (7) and provides essential metabolites (i.e., sterols and non-sterol intermediates) that collectively drive tumor growth and development.